142 related articles for article (PubMed ID: 12445232)
1. Expression and somatic mutation on androgen receptor gene in prostate cancer.
Segawa N; Nakamura M; Shan L; Utsunomiya H; Nakamura Y; Mori I; Katsuoka Y; Kakudo K
Int J Urol; 2002 Oct; 9(10):545-53. PubMed ID: 12445232
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor mutants detected in recurrent prostate cancer exhibit diverse functional characteristics.
Chen G; Wang X; Zhang S; Lu Y; Sun Y; Zhang J; Li Z; Lu J
Prostate; 2005 Jun; 63(4):395-406. PubMed ID: 15617028
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.
Taplin ME; Rajeshkumar B; Halabi S; Werner CP; Woda BA; Picus J; Stadler W; Hayes DF; Kantoff PW; Vogelzang NJ; Small EJ;
J Clin Oncol; 2003 Jul; 21(14):2673-8. PubMed ID: 12860943
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.
Tilley WD; Buchanan G; Hickey TE; Bentel JM
Clin Cancer Res; 1996 Feb; 2(2):277-85. PubMed ID: 9816170
[TBL] [Abstract][Full Text] [Related]
5. [Androgen receptor gene mutations in prostate cancer].
Wang C; Uchida T
Nihon Hinyokika Gakkai Zasshi; 1997 May; 88(5):550-6. PubMed ID: 9184448
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor gene mutations in hormone-refractory prostate cancer.
Wallén MJ; Linja M; Kaartinen K; Schleutker J; Visakorpi T
J Pathol; 1999 Dec; 189(4):559-63. PubMed ID: 10629558
[TBL] [Abstract][Full Text] [Related]
7. Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome.
Suzuki H; Akakura K; Komiya A; Aida S; Akimoto S; Shimazaki J
Prostate; 1996 Sep; 29(3):153-8. PubMed ID: 8827083
[TBL] [Abstract][Full Text] [Related]
8. The Significance of ERG and Androgen Receptor Expression in Adenocarcinoma Prostate.
Husain I; Sagar P; Shukla S; Babu S; Singhai A; Sankhwar SN; Husain N
Kathmandu Univ Med J (KUMJ); 2018 Oct.-Dec.; 16(64):277-280. PubMed ID: 31729338
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor mutations in high-grade prostate cancer before hormonal therapy.
Thompson J; Hyytinen ER; Haapala K; Rantala I; Helin HJ; Jänne OA; Palvimo JJ; Koivisto PA
Lab Invest; 2003 Dec; 83(12):1709-13. PubMed ID: 14691288
[TBL] [Abstract][Full Text] [Related]
10. [Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer].
Castagnaro M; Yandell DW; Dockhorn-Dworniczak B; Wolfe HJ; Poremba C
Verh Dtsch Ges Pathol; 1993; 77():119-23. PubMed ID: 7511268
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the androgen receptor to prostate cancer predisposition and progression.
Buchanan G; Irvine RA; Coetzee GA; Tilley WD
Cancer Metastasis Rev; 2001; 20(3-4):207-23. PubMed ID: 12085963
[TBL] [Abstract][Full Text] [Related]
12. A genetic sequence change in the 3'-noncoding region of the androgen receptor gene in prostate carcinoma.
Paz A; Lindner A; Zisman A; Siegel Y
Eur Urol; 1997; 31(2):209-15. PubMed ID: 9076468
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations of androgen receptor gene in Japanese human prostate cancer.
Watanabe M; Ushijima T; Shiraishi T; Yatani R; Shimazaki J; Kotake T; Sugimura T; Nagao M
Jpn J Clin Oncol; 1997 Dec; 27(6):389-93. PubMed ID: 9438000
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor action in hormone-dependent and recurrent prostate cancer.
Agoulnik IU; Weigel NL
J Cell Biochem; 2006 Oct; 99(2):362-72. PubMed ID: 16619264
[TBL] [Abstract][Full Text] [Related]
15. Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.
Hess-Wilson JK; Webb SL; Daly HK; Leung YK; Boldison J; Comstock CE; Sartor MA; Ho SM; Knudsen KE
Environ Health Perspect; 2007 Nov; 115(11):1646-53. PubMed ID: 18007998
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.
Koivisto P; Kononen J; Palmberg C; Tammela T; Hyytinen E; Isola J; Trapman J; Cleutjens K; Noordzij A; Visakorpi T; Kallioniemi OP
Cancer Res; 1997 Jan; 57(2):314-9. PubMed ID: 9000575
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy.
Sadi MV; Walsh PC; Barrack ER
Cancer; 1991 Jun; 67(12):3057-64. PubMed ID: 1710537
[TBL] [Abstract][Full Text] [Related]
18. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
[TBL] [Abstract][Full Text] [Related]
19. DJ-1 and androgen receptor immunohistochemical expression in prostatic carcinoma: a possible role in carcinogenesis.
Osman WM; Abd El Atti RM; Abou Gabal HH
J Egypt Natl Canc Inst; 2013 Dec; 25(4):223-30. PubMed ID: 24207095
[TBL] [Abstract][Full Text] [Related]
20. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
Rosner IL; Ravindranath L; Furusato B; Chen Y; Gao C; Cullen J; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G
Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
